Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Dominari Holdings PE Ratio 2010-2025 | DOMH

Current and historical p/e ratio for Dominari Holdings (DOMH) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Dominari Holdings PE ratio as of July 14, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
  
Dominari Holdings PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-07-15 5.22 0.00
2025-03-31 4.00 $-4.50 0.00
2024-12-31 0.95 $-2.39 0.00
2024-09-30 1.78 $-3.87 0.00
2024-06-30 1.80 $-3.86 0.00
2024-03-31 2.35 $-4.64 0.00
2023-12-31 2.49 $-4.44 0.00
2023-09-30 2.23 $-3.16 0.00
2023-06-30 2.80 $-3.67 0.00
2023-03-31 3.09 $-3.06 0.00
2022-12-31 3.15 $-3.54 0.00
2022-09-30 6.57 $-3.88 0.00
2022-06-30 5.67 $-2.71 0.00
2022-03-31 7.35 $-1.87 0.00
2021-12-31 9.59 $-1.87 0.00
2021-09-30 13.46 $-0.68 0.00
2021-06-30 15.63 $-1.70 0.00
2021-03-31 18.62 $-2.55 0.00
2020-12-31 14.27 $-16.84 0.00
2020-09-30 10.03 $-17.69 0.00
2020-06-30 13.40 $-40.14 0.00
2020-03-31 8.28 $-44.05 0.00
2019-12-31 21.56 $-38.26 0.00
2019-09-30 24.66 $11.57 2.13
2019-06-30 36.70 $35.03 1.05
2019-03-31 56.84 $40.14 1.42
2018-12-31 40.19 $33.21 1.21
2018-09-30 62.46 $-28.19 0.00
2018-06-30 66.21 $-28.19 0.00
2018-03-31 74.95 $-55.65 0.00
2017-12-31 87.44 $-52.76 0.00
2017-09-30 93.06 $-166.96 0.00
2017-06-30 162.39 $-174.91 0.00
2017-03-31 77.45 $518.23 0.15
2016-12-31 64.96 $513.17 0.13
2016-09-30 82.45 $638.93 0.13
2016-06-30 148.66 $536.95 0.28
2016-03-31 113.05 $-2,066.19 0.00
2015-12-31 173.62 $-2,239.77 0.00
2015-09-30 403.49 $-2,239.77 0.00
2015-06-30 569.63 $-2,377.18 0.00
2015-03-31 992.46 $-1,387.83 0.00
2014-12-31 1281.67 $-3,476.45 0.00
2014-09-30 1851.30 $-3,476.45 0.00
2014-06-30 2124.25 $-12,751.55 0.00
2014-03-31 3548.32 $-10,236.97 0.00
2013-12-31 9565.04 $-7,955.98 0.00
2013-09-30 9422.63 $-7,955.98 0.00
2013-06-30 5280.95 $-3,503.93 0.00
2013-03-31 9671.97 $-10,017.11 0.00
2012-12-31 8100.62 $-18,536.47 0.00
2012-09-30 13955.90 $-31,178.09 0.00
2012-06-30 13766.10 $-36,001.14 0.00
2012-03-31 20649.10 $-42,047.13 0.00
2011-12-31 27769.50 $-36,275.95 0.00
2011-09-30 47469.20 $-31,878.87 0.00
2011-06-30 56013.60 $-54,963.57 0.00
2011-03-31 104432.00 $-85,193.54 0.00
2010-12-31 168516.00 $-118,171.68 0.00
2010-09-30 365513.00 $-170,387.07 0.00
2010-06-30 320417.00 $-178,631.61 0.00
2010-03-31 332284.00 $-167,638.90 0.00
2009-12-31 270574.00 $-170,387.08 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.078B $0.018B
Dominari Holdings Inc. primarily focused on the development of a diverse portfolio of small-molecule anticancer and antiviral therapeutics and related patent technology. The Company's fintech and financial services business will be operated through its subsidiary, Dominari Financial Inc. Dominari Holdings Inc., formerly known as AIkido Pharma Inc., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $76.549B 28.72
Zoetis (ZTS) United States $69.297B 25.85
Takeda Pharmaceutical (TAK) Japan $47.856B 9.52
Daiichi Sankyo, - (DSNKY) Japan $42.661B 21.86
BeOne Medicines - (ONC) Cayman Islands $27.635B 0.00
Sandoz Group AG (SDZNY) Switzerland $24.908B 0.00
Summit Therapeutics (SMMT) United States $18.864B 0.00
Merck (MKKGY) Germany $16.659B 12.21
Shionogi (SGIOY) Japan $14.241B 14.27
United Therapeutics (UTHR) United States $13.427B 11.88
Neurocrine Biosciences (NBIX) United States $13.373B 45.81
Orion OYJ (ORINY) Finland $11.038B 29.85
IPSEN (IPSEY) France $10.299B 0.00
Stevanato Group S.p.A (STVN) Italy $7.768B 47.50
Corcept Therapeutics (CORT) United States $7.717B 62.73
Madrigal Pharmaceuticals (MDGL) United States $7.102B 0.00
Ionis Pharmaceuticals (IONS) United States $6.772B 0.00
Grifols, S.A (GRFS) Spain $6.683B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.265B 16.01
Soleno Therapeutics (SLNO) United States $4.171B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.092B 0.00
Hypermarcas (HYPMY) Brazil $3.025B 19.90
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.639B 14.27
Catalyst Pharmaceuticals (CPRX) United States $2.637B 9.24
NewAmsterdam Pharma (NAMS) Netherlands $2.489B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.021B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.875B 0.00
Ocular Therapeutix (OCUL) United States $1.795B 0.00
ARS Pharmaceuticals (SPRY) United States $1.758B 0.00
Endo (NDOI) United States $1.588B 0.00
Evotec AG (EVO) Germany $1.463B 0.00
Harrow (HROW) United States $1.307B 0.00
Guardian Pharmacy Services (GRDN) United States $1.290B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.221B 24.43
Enliven Therapeutics (ELVN) United States $1.129B 0.00
Ardelyx (ARDX) United States $1.103B 0.00
ProKidney (PROK) United States $1.080B 0.00
Collegium Pharmaceutical (COLL) United States $1.055B 5.69
Akebia Therapeutics (AKBA) United States $1.043B 0.00
Dyne Therapeutics (DYN) United States $1.013B 0.00
Verve Therapeutics (VERV) United States $0.983B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.971B 0.00
Xeris Biopharma Holdings (XERS) United States $0.851B 0.00
Cronos Group (CRON) Canada $0.798B 0.00
KalVista Pharmaceuticals (KALV) United States $0.760B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.750B 0.00
Zevra Therapeutics (ZVRA) United States $0.699B 0.00
Xencor (XNCR) United States $0.630B 0.00
Relay Therapeutics (RLAY) United States $0.610B 0.00
USANA Health Sciences (USNA) United States $0.607B 13.19
Elite Pharmaceuticals (ELTP) United States $0.575B 0.00
Theravance Biopharma (TBPH) United States $0.574B 0.00
Organogenesis (ORGO) United States $0.570B 0.00
Bioventus (BVS) United States $0.559B 14.19
Oruka Therapeutics (ORKA) United States $0.550B 0.00
Siga Technologies (SIGA) United States $0.490B 10.24
Tourmaline Bio (TRML) United States $0.487B 0.00
Savara (SVRA) United States $0.434B 0.00
Aquestive Therapeutics (AQST) United States $0.400B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.346B 9.35
Altimmune (ALT) United States $0.346B 0.00
Heron Therapeutics (HRTX) United States $0.323B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.315B 0.00
AleAnna (ANNA) United States $0.314B 0.00
Nektar Therapeutics (NKTR) United States $0.303B 0.00
Aldeyra Therapeutics (ALDX) United States $0.300B 0.00
Nature's Sunshine Products (NATR) United States $0.292B 26.76
OmniAb (OABI) United States $0.250B 0.00
Nanobiotix S.A (NBTX) France $0.243B 0.00
Esperion Therapeutics (ESPR) United States $0.234B 0.00
MediWound (MDWD) Israel $0.221B 0.00
Larimar Therapeutics (LRMR) United States $0.221B 0.00
4D Molecular Therapeutics (FDMT) United States $0.203B 0.00
China SXT Pharmaceuticals (SXTC) China $0.193B 0.00
Galectin Therapeutics (GALT) United States $0.180B 0.00
Profound Medical (PROF) Canada $0.173B 0.00
Journey Medical (DERM) United States $0.173B 0.00
Aclaris Therapeutics (ACRS) United States $0.171B 0.00
Liminatus Pharma (LIMN) United States $0.165B 0.00
Avita Medical (RCEL) United States $0.155B 0.00
Lexeo Therapeutics (LXEO) United States $0.147B 0.00
Inhibikase Therapeutics (IKT) United States $0.144B 0.00
Lyell Immunopharma (LYEL) United States $0.143B 0.00
Protara Therapeutics (TARA) United States $0.122B 0.00
Korro Bio (KRRO) United States $0.122B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.119B 0.00
Champions Oncology (CSBR) United States $0.110B 18.11
Cardiol Therapeutics (CRDL) Canada $0.110B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cassava Sciences (SAVA) United States $0.104B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.102B 0.00
VAXART, INC (VXRT) United States $0.098B 0.00
Achieve Life Sciences (ACHV) Canada $0.095B 0.00
Jupiter Neurosciences (JUNS) United States $0.093B 0.00
Nutriband (NTRB) United States $0.090B 0.00
Vivani Medical (VANI) United States $0.088B 0.00
Metagenomi (MGX) United States $0.084B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Rafael Holdings (RFL) United States $0.078B 0.00
Fractyl Health (GUTS) United States $0.077B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Surrozen (SRZN) United States $0.074B 0.00
PMV Pharmaceuticals (PMVP) United States $0.070B 0.00
Inotiv (NOTV) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.066B 0.00
Context Therapeutics (CNTX) United States $0.066B 0.00
Wellgistics Health (WGRX) United States $0.062B 0.00
Unicycive Therapeutics (UNCY) United States $0.062B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Klotho Neurosciences (KLTO) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.056B 0.00
NRx Pharmaceuticals (NRXP) United States $0.056B 0.00
ElectroCore (ECOR) United States $0.055B 0.00
Avalo Therapeutics (AVTX) United States $0.053B 0.00
Century Therapeutics (IPSC) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 37.78
Prelude Therapeutics (PRLD) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
Karyopharm Therapeutics (KPTI) United States $0.041B 0.00
Vivos Therapeutics (VVOS) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Telomir Pharmaceuticals (TELO) United States $0.035B 0.00
PolyPid (PYPD) Israel $0.035B 0.00
SCYNEXIS (SCYX) United States $0.032B 0.00
FibroGen (FGEN) United States $0.031B 0.00
Enlivex Therapeutics (ENLV) Israel $0.030B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Scienture Holdings (SCNX) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.021B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
Carisma Therapeutics (CARM) United States $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
CASI Pharmaceuticals (CASI) China $0.018B 0.00
DURECT (DRRX) United States $0.017B 0.00
Plus Therapeutics (PSTV) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.17
BioVie (BIVI) United States $0.012B 0.00
Ainos (AIMD) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Talphera (TLPH) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Qualigen Therapeutics (QLGN) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.13
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00